Vitamin D through the vitamin D receptor (VDR) is involved in the control of bone and calcium homeostasis, immunoregulation, cellular differentiation,and antiinflammatoryactions.The liver is central in vitamin D synthesis, however the direct involvement ofthe vitamin D with chronic liver disease, chronic hepatitis C (CHC) infection, and hepatocellular carcinoma (HCC) remains to be evaluated.The purpose of thisreview is to describevitamin D metabolism, the mechanisms of homeostatic control, and to address the associationsbetween vitamin D and HCV-related liver disease.
Introduction
Vitamin D,the "sunshine vitamin", is an important secosteroid hormone with pleiotropiceffects. While its role in the regulation of calcium andbone homeostasis is well established,recently there is increasingrecognition that vitamin D has immunomodulatory, antiinflammatory and anti-fibrotic properties and plays an importantrole in the regulation of cell proliferation and differentiation. These extraskeletal effects are relevant in the pathogenesis andtreatment of many causes of chronic liver disease, including HCV(1).
Sources of vitamin D
Several forms of vitamin D exist, the two major forms are vitamin D 2 (ergocalciferol), and vitamin D 3 (cholecalciferol).Vitamin D 3 is produced in the skin from 7-dehydrocholesterol (7-DHC) through a two-step process in which the B ring is broken by ultraviolet (UV)radiation (spectrum 280-320 UVB) from the sunlight, forming previtamin D 3 that isomerizes to vitamin D 3 in a thermosensitive but noncatalytic process (Figure 1 ).Both UVB intensity and skin pigmentation level contribute to the rate of vitamin D 3 formation (2).Vitamin D is not widely present in nature; however, its provitamins are common in both plants and animals.The richest food sources of vitamin D are oily fishes (Salmon, Mackerel, Tuna, Herring and Sardines) and their products, dairy products, irradiated mushrooms, and fortified foods oils (1).
Vitamin D metabolism
The two forms of vitamin D (D 3 and D 2 ) are biologically inactive; they require activation in the liver and kidney, through 25-and 1α-hydroxylation to produce the active form 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 , calcitriol). Calcitriol then undergo catabolism via 24-hydroxylation (Figure 1) This suggests signaling independent of genomic responses, which typically take hours to days (1). The first such response to be recognized is transcaltachia, the rapid transport of calcium across the intestinal mucosa (7).Several other transcriptionindependent responses have since been demonstrated including phosphoinositide metabolism, cytosolic calcium levels, cGMP levels, phospholipase C, protein kinase C (PKC), mitogen activated protein (MAP) kinases, and the opening of chloride channels(6). Vitamin D deficiency in CLD is reported to increase the degree of necroinflammation and exacerbate the progression of liver fibrosis. Moreover, it is partly responsible for the development of hepatic osteodystrophy, which refers to the specific CLD-associated bone disease and related metabolism abnormalities with both osteopenia and osteoporosis (22). Vitamin D and chronic hepatitis C Hepatitis C virus (HCV) infection is one of the major public health problems worldwide. Estimates indicate that about 71 million people are chronically infected, with three to four million persons are newly infected, and 399,000 deaths occur each year due to all HCV-related causes(23). Chronic hepatitis C(CHC) infection, defined by persistence of HCV RNA in the blood of more than 6 months, is characterized by a high rate of progression to fibrosis, chronic hepatitis, leading to cirrhosis and ultimately to hepatocellular carcinoma (HCC) (24) . Vitamin D deficiency is more prevalent in CHC subjects than healthy controls, even in those with minimal liver fibrosis. The majority of subjects with CHC are vitamin D deficient (<50 nmol/L) with 25% having severe deficiency (<25 nmol/L) (25). 
